IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v22y2025i2p176-d1578659.html
   My bibliography  Save this article

An Investigation of Travel Distance and Timeliness of Breast Cancer Treatment Among a Diverse Cohort in the United States

Author

Listed:
  • Swann Arp Adams

    (Department of Biobehavioral Health and Nursing Science, College of Nursing, University of South Carolina, Columbia, SC 29208, USA
    Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA)

  • Oluwole Adeyemi Babatunde

    (Department of Psychiatry, Prisma Health, Greer, SC 29650, USA)

  • Whitney E. Zahnd

    (Department of Health Policy and Management, College of Public Health, University of Iowa, Iowa City, IA 52242, USA)

  • Peiyin Hung

    (Health Services, Policy, and Management Department, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA
    Rural and Minority Health Research Center, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA)

  • Karen E. Wickersham

    (Department of Biobehavioral Health and Nursing Science, College of Nursing, University of South Carolina, Columbia, SC 29208, USA)

  • Nathaniel Bell

    (Institute for Families in Society, College of Social Work, University of South Carolina, Columbia, SC 29208, USA)

  • Jan M. Eberth

    (Department of Health Management and Policy, Drexel University, Philadelphia, PA 19104, USA)

Abstract

Travel to and from distant cancer treatment facilities can place a significant burden on cancer patients, particularly rural and minority survivors. Thus, the purpose of our investigation was to examine the association between patient travel distance and delays in types of treatment for breast cancer (surgery, radiation, chemotherapy, and hormonal therapy) and treatment delays. Using a novel linkage between the state cancer registry and administrative data from Medicaid and a private insurance plan, 2155 BC patients were successfully linked to create the cohort. ArcGIS was used to geocode all case residences and treatment facility addresses and calculate network distance between the residence and each facility. Logistic regression models were used to calculate the adjusted odds of being delayed versus timely by street distance. Odds of late surgery were increased by 1% (95% CI: 1.00, 1.01) for each one-mile increase from the patient’s residence to the treatment facility. In race-stratified models, the odds of late treatment for Black patients increased by 3% per mile (95% CI 1.01, 1.06) for radiation. Increased travel distance appears to significantly increase treatment delays for surgical, radiation, and chemotherapeutic treatments for women with BC, especially among Black women.

Suggested Citation

  • Swann Arp Adams & Oluwole Adeyemi Babatunde & Whitney E. Zahnd & Peiyin Hung & Karen E. Wickersham & Nathaniel Bell & Jan M. Eberth, 2025. "An Investigation of Travel Distance and Timeliness of Breast Cancer Treatment Among a Diverse Cohort in the United States," IJERPH, MDPI, vol. 22(2), pages 1-13, January.
    • Handle: RePEc:gam:jijerp:v:22:y:2025:i:2:p:176-:d:1578659
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/22/2/176/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/22/2/176/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Daniela R. Bien & Marion Danner & Vera Vennedey & Daniele Civello & Silvia M. Evers & Mickaël Hiligsmann, 2017. "Patients’ Preferences for Outcome, Process and Cost Attributes in Cancer Treatment: A Systematic Review of Discrete Choice Experiments," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 10(5), pages 553-565, October.
    2. Alok A Khorana & Katherine Tullio & Paul Elson & Nathan A Pennell & Stephen R Grobmyer & Matthew F Kalady & Daniel Raymond & Jame Abraham & Eric A Klein & R Matthew Walsh & Emily E Monteleone & Wei We, 2019. "Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-2, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Alene Sze Jing Yong & Yi Heng Lim & Mark Wing Loong Cheong & Ednin Hamzah & Siew Li Teoh, 2022. "Willingness-to-pay for cancer treatment and outcome: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(6), pages 1037-1057, August.
    2. Vikas Soekhai & Esther W. Bekker-Grob & Alan R. Ellis & Caroline M. Vass, 2019. "Discrete Choice Experiments in Health Economics: Past, Present and Future," PharmacoEconomics, Springer, vol. 37(2), pages 201-226, February.
    3. Moonsammy, Stephan & Boman, Mattias & Ramdhanie, Vidwatee & Renn-Moonsammy, Donna-Marie, 2024. "State-of-the art valuation of wetland ecosystem services in Small Island Developing States: A systematic review with an emphasis on future research needs," Ecosystem Services, Elsevier, vol. 68(C).
    4. Shan Jiang & Ru Ren & Yuanyuan Gu & Varinder Jeet & Ping Liu & Shunping Li, 2023. "Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments," PharmacoEconomics, Springer, vol. 41(1), pages 43-57, January.
    5. Vo, Linh K. & Allen, Michelle J. & Cunich, Michelle & Thillainadesan, Janani & McPhail, Steven M. & Sharma, Pakhi & Wallis, Shannon & McGowan, Kelly & Carter, Hannah E., 2024. "Stakeholders’ preferences for the design and delivery of virtual care services: A systematic review of discrete choice experiments," Social Science & Medicine, Elsevier, vol. 340(C).
    6. Mo Zhou & Winter Maxwell Thayer & John F. P. Bridges, 2018. "Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review," PharmacoEconomics, Springer, vol. 36(2), pages 175-187, February.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:22:y:2025:i:2:p:176-:d:1578659. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.